Global, regional, and national children and adolescent epilepsy burden, 1990–2021: an analysis based on the global burden of disease study 2021

This study highlights the global changes in the disease burden of epilepsy in children and adolescents. Population factors have been identified as the primary drivers of the increasing burden, while improvements in public health policies and access to treatments have contributed to the decreasing burden. Despite the expected rise in the future incidence, targeted improvements in treatment accessibility and health budget allocations are essential to reduce the long-term burden of epilepsy.